Today: 21 May 2026
Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates
7 January 2026
1 min read

Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates

New York, January 6, 2026, 21:40 EST — Market closed

  • Intuitive Surgical shares closed up 4.7% on Tuesday, extending a two-day rise
  • Focus turns to the company’s Jan. 14 conference presentation and Jan. 22 quarterly call
  • Traders watch Wednesday’s U.S. data for interest-rate cues that can sway growth stocks

Intuitive Surgical (ISRG) shares rose 4.7% on Tuesday to close at $592.85, outpacing several large-cap medical device peers as U.S. stocks advanced broadly.

The gain left the surgical-robot maker about 3.8% below its 52-week high of $616, a level some investors view as a near-term marker after the stock’s sharp run since early January.

That matters now because Intuitive is entering a stretch when management commentary can reset expectations, with investors looking for early signals on demand and margins before the next earnings update.

Tuesday’s session was active. ISRG traded about 2.6 million shares, above its 50-day average of 1.8 million, and swung between roughly $564 and $595, market data showed.

Intuitive is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Jan. 14. It has also listed a fourth-quarter 2025 earnings conference call for Jan. 22 at 1:30 p.m. PST (4:30 p.m. ET).

Investors will be listening for updates on procedure growth, hospital capital spending and gross margin — the share of revenue left after production costs — after the company previously raised its 2025 adjusted gross margin forecast in its October results.

Still, the setup cuts both ways. Intuitive trades at a premium to many medtech peers, and any sign of slower procedure growth, pricing pressure, or higher costs could sharpen the stock’s swings into results.

Before the next session, traders also face a slate of U.S. releases on Wednesday including ADP employment, the ISM services index and the JOLTS job openings report, all of which can move rate expectations and high-multiple stocks. The next company checkpoints are Jan. 14 and Jan. 22.

Stock Market Today

  • Actor Niko Foster lists Nevada mansion for $22 million
    May 21, 2026, 5:17 AM EDT. Actor Niko Foster is selling a 14,000-square-foot mansion near Las Vegas for $22 million. The home offers unobstructed views of the Las Vegas Strip and features a range of upscale amenities. Located in an exclusive community, the property stands out for its size and luxury.

Latest articles

Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

21 May 2026
Snowflake shares fell 1.5% to $166.97 in early Thursday trading after Bank of America raised its price target to $205 and reiterated a Buy rating ahead of fiscal Q1 results due May 27. RBC cut its target earlier this week, highlighting ongoing competition in data and AI. Snowflake previously guided for Q1 product revenue of $1.262–$1.267 billion, up 27% year-over-year.
Arm jumps in premarket on AI chip hopes

Arm jumps in premarket on AI chip hopes

21 May 2026
Arm Holdings shares closed Wednesday at $256.73, up 15.05%, after Bernstein’s David Dai initiated coverage with an outperform rating and a $300 target, citing rising demand for server CPUs driven by agentic AI. The stock touched $259.44 during regular trading. U.S. markets were open; May 21 is not a listed exchange holiday. Arm’s AGI CPU has over $2 billion in expected demand for fiscal 2027 and 2028.
T1 Energy Stock Jumps 26% as Roth Pushback Turns Short-Seller Hit Into a Rally

T1 Energy Stock Jumps 26% as Roth Pushback Turns Short-Seller Hit Into a Rally

21 May 2026
T1 Energy Inc. shares jumped 26.45% to $8.70 Wednesday after heavy trading and recent volatility. The move follows a short-seller report alleging hidden Chinese ties and tax-credit risks, countered by a Roth Capital analyst’s defense and news of a major institutional stake. T1 reported a $21.4 million net loss but positive adjusted EBITDA and maintained its 2026 production guidance.
Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus
Previous Story

Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Next Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

Go toTop